Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations

The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conduc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical biochemistry 2011-07, Vol.44 (10), p.889-893
Hauptverfasser: Karnpean, Rossarin, Pansuwan, Anupong, Fucharoen, Goonnapa, Fucharoen, Supan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 893
container_issue 10
container_start_page 889
container_title Clinical biochemistry
container_volume 44
creator Karnpean, Rossarin
Pansuwan, Anupong
Fucharoen, Goonnapa
Fucharoen, Supan
description The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conducted initially on 279 subjects with various thalassemia genotypes. Validation was performed additionally in a cohort of another unrelated 313 subjects. The best cut off values of MCV and MCH were found to be 78 fL and 27 pg, respectively. Using these cut off values in combination with the dichlorophenolindophenol test in screening of α 0 thalassemia, β thalassemia and Hb E in a cohort study revealed 100% sensitivity, 79.6% specificity, 80.0% positive predictive value and 100% negative predictive value. The combined blood cell counting using the URIT-2900 Automated Hematology Analyzer and dichlorophenolindophenol test is suitable for population screening of thalassemia and hemoglobinopathies in Southeast Asia.
doi_str_mv 10.1016/j.clinbiochem.2011.04.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_871965676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009912011003146</els_id><sourcerecordid>871965676</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-b1fc5c0128ecbf1efb9216ed17de8e24dc49c5b71734c06d2b70dc9a29b6e5bc3</originalsourceid><addsrcrecordid>eNqNkc1uEzEUhS0EoqHlFZBZIFYz2J5fL6Oo0EqVKtF2bfnnTuLIYw_2TKX0GXhoXBIKS1ZXtr5z79E5CH2kpKSEtl_2pXbWKxv0DsaSEUpLUpeE8FdoRfuuKhivqtdoRfJXwSkjZ-hdSvv8ZHXfvkVnjDYV7xlZoZ-Xj9ItcrbB4zDgeQf44fv1fd5ACF4vcxjlDAZfQZ7Bhe0Br710hyeIeAgRJx0BvPXbo1g6mRKMVmLpDc7mwtYFZX2Y5LyzkLD1-C4s-YpMM14nKz2ewrS43wbSBXozSJfg_Wmeo4evl_ebq-Lm9tv1Zn1T6Jq0c6HooBtNKOtBq4HCoDijLRjaGeiB1UbXXDeqo11Va9IapjpiNJeMqxYapatz9Pm4d4rhxwJpFqNNGpyTHsKSRN9R3jZt12aSH0kdQ0oRBjFFO8p4EJSI5y7EXvzThXjuQpBa5OCz9sPpyqJGMC_KP-Fn4NMJkElLN0TptU1_ubqqmq7vM7c5cpAzebQQRdIWvAZjI-hZmGD_w84vhVuw3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871965676</pqid></control><display><type>article</type><title>Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Karnpean, Rossarin ; Pansuwan, Anupong ; Fucharoen, Goonnapa ; Fucharoen, Supan</creator><creatorcontrib>Karnpean, Rossarin ; Pansuwan, Anupong ; Fucharoen, Goonnapa ; Fucharoen, Supan</creatorcontrib><description>The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conducted initially on 279 subjects with various thalassemia genotypes. Validation was performed additionally in a cohort of another unrelated 313 subjects. The best cut off values of MCV and MCH were found to be 78 fL and 27 pg, respectively. Using these cut off values in combination with the dichlorophenolindophenol test in screening of α 0 thalassemia, β thalassemia and Hb E in a cohort study revealed 100% sensitivity, 79.6% specificity, 80.0% positive predictive value and 100% negative predictive value. The combined blood cell counting using the URIT-2900 Automated Hematology Analyzer and dichlorophenolindophenol test is suitable for population screening of thalassemia and hemoglobinopathies in Southeast Asia.</description><identifier>ISSN: 0009-9120</identifier><identifier>EISSN: 1873-2933</identifier><identifier>DOI: 10.1016/j.clinbiochem.2011.04.009</identifier><identifier>PMID: 21539820</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Anemias. Hemoglobinopathies ; Asia, Southeastern ; Automation ; Biological and medical sciences ; Cellular Senescence ; Cohort Studies ; Diseases of red blood cells ; Erythrocyte Indices ; Genotype ; Hematologic and hematopoietic diseases ; Hematology - instrumentation ; Hemoglobins - metabolism ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Mass Screening ; Medical sciences ; Population screening ; Red blood cell indices ; Reproducibility of Results ; ROC Curve ; Thalassemia - blood ; Thalassemia - diagnosis ; Thalassemia - genetics ; Thalassemia - pathology ; Thalassemia and hemoglobinopathies ; URIT-2900 Hematology Analyzer</subject><ispartof>Clinical biochemistry, 2011-07, Vol.44 (10), p.889-893</ispartof><rights>2011 The Canadian Society of Clinical Chemists</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-b1fc5c0128ecbf1efb9216ed17de8e24dc49c5b71734c06d2b70dc9a29b6e5bc3</citedby><cites>FETCH-LOGICAL-c406t-b1fc5c0128ecbf1efb9216ed17de8e24dc49c5b71734c06d2b70dc9a29b6e5bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009912011003146$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24335788$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21539820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karnpean, Rossarin</creatorcontrib><creatorcontrib>Pansuwan, Anupong</creatorcontrib><creatorcontrib>Fucharoen, Goonnapa</creatorcontrib><creatorcontrib>Fucharoen, Supan</creatorcontrib><title>Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations</title><title>Clinical biochemistry</title><addtitle>Clin Biochem</addtitle><description>The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conducted initially on 279 subjects with various thalassemia genotypes. Validation was performed additionally in a cohort of another unrelated 313 subjects. The best cut off values of MCV and MCH were found to be 78 fL and 27 pg, respectively. Using these cut off values in combination with the dichlorophenolindophenol test in screening of α 0 thalassemia, β thalassemia and Hb E in a cohort study revealed 100% sensitivity, 79.6% specificity, 80.0% positive predictive value and 100% negative predictive value. The combined blood cell counting using the URIT-2900 Automated Hematology Analyzer and dichlorophenolindophenol test is suitable for population screening of thalassemia and hemoglobinopathies in Southeast Asia.</description><subject>Anemias. Hemoglobinopathies</subject><subject>Asia, Southeastern</subject><subject>Automation</subject><subject>Biological and medical sciences</subject><subject>Cellular Senescence</subject><subject>Cohort Studies</subject><subject>Diseases of red blood cells</subject><subject>Erythrocyte Indices</subject><subject>Genotype</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology - instrumentation</subject><subject>Hemoglobins - metabolism</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>Population screening</subject><subject>Red blood cell indices</subject><subject>Reproducibility of Results</subject><subject>ROC Curve</subject><subject>Thalassemia - blood</subject><subject>Thalassemia - diagnosis</subject><subject>Thalassemia - genetics</subject><subject>Thalassemia - pathology</subject><subject>Thalassemia and hemoglobinopathies</subject><subject>URIT-2900 Hematology Analyzer</subject><issn>0009-9120</issn><issn>1873-2933</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1uEzEUhS0EoqHlFZBZIFYz2J5fL6Oo0EqVKtF2bfnnTuLIYw_2TKX0GXhoXBIKS1ZXtr5z79E5CH2kpKSEtl_2pXbWKxv0DsaSEUpLUpeE8FdoRfuuKhivqtdoRfJXwSkjZ-hdSvv8ZHXfvkVnjDYV7xlZoZ-Xj9ItcrbB4zDgeQf44fv1fd5ACF4vcxjlDAZfQZ7Bhe0Br710hyeIeAgRJx0BvPXbo1g6mRKMVmLpDc7mwtYFZX2Y5LyzkLD1-C4s-YpMM14nKz2ewrS43wbSBXozSJfg_Wmeo4evl_ebq-Lm9tv1Zn1T6Jq0c6HooBtNKOtBq4HCoDijLRjaGeiB1UbXXDeqo11Va9IapjpiNJeMqxYapatz9Pm4d4rhxwJpFqNNGpyTHsKSRN9R3jZt12aSH0kdQ0oRBjFFO8p4EJSI5y7EXvzThXjuQpBa5OCz9sPpyqJGMC_KP-Fn4NMJkElLN0TptU1_ubqqmq7vM7c5cpAzebQQRdIWvAZjI-hZmGD_w84vhVuw3w</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Karnpean, Rossarin</creator><creator>Pansuwan, Anupong</creator><creator>Fucharoen, Goonnapa</creator><creator>Fucharoen, Supan</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations</title><author>Karnpean, Rossarin ; Pansuwan, Anupong ; Fucharoen, Goonnapa ; Fucharoen, Supan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-b1fc5c0128ecbf1efb9216ed17de8e24dc49c5b71734c06d2b70dc9a29b6e5bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anemias. Hemoglobinopathies</topic><topic>Asia, Southeastern</topic><topic>Automation</topic><topic>Biological and medical sciences</topic><topic>Cellular Senescence</topic><topic>Cohort Studies</topic><topic>Diseases of red blood cells</topic><topic>Erythrocyte Indices</topic><topic>Genotype</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology - instrumentation</topic><topic>Hemoglobins - metabolism</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>Population screening</topic><topic>Red blood cell indices</topic><topic>Reproducibility of Results</topic><topic>ROC Curve</topic><topic>Thalassemia - blood</topic><topic>Thalassemia - diagnosis</topic><topic>Thalassemia - genetics</topic><topic>Thalassemia - pathology</topic><topic>Thalassemia and hemoglobinopathies</topic><topic>URIT-2900 Hematology Analyzer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karnpean, Rossarin</creatorcontrib><creatorcontrib>Pansuwan, Anupong</creatorcontrib><creatorcontrib>Fucharoen, Goonnapa</creatorcontrib><creatorcontrib>Fucharoen, Supan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karnpean, Rossarin</au><au>Pansuwan, Anupong</au><au>Fucharoen, Goonnapa</au><au>Fucharoen, Supan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations</atitle><jtitle>Clinical biochemistry</jtitle><addtitle>Clin Biochem</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>44</volume><issue>10</issue><spage>889</spage><epage>893</epage><pages>889-893</pages><issn>0009-9120</issn><eissn>1873-2933</eissn><abstract>The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conducted initially on 279 subjects with various thalassemia genotypes. Validation was performed additionally in a cohort of another unrelated 313 subjects. The best cut off values of MCV and MCH were found to be 78 fL and 27 pg, respectively. Using these cut off values in combination with the dichlorophenolindophenol test in screening of α 0 thalassemia, β thalassemia and Hb E in a cohort study revealed 100% sensitivity, 79.6% specificity, 80.0% positive predictive value and 100% negative predictive value. The combined blood cell counting using the URIT-2900 Automated Hematology Analyzer and dichlorophenolindophenol test is suitable for population screening of thalassemia and hemoglobinopathies in Southeast Asia.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>21539820</pmid><doi>10.1016/j.clinbiochem.2011.04.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9120
ispartof Clinical biochemistry, 2011-07, Vol.44 (10), p.889-893
issn 0009-9120
1873-2933
language eng
recordid cdi_proquest_miscellaneous_871965676
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anemias. Hemoglobinopathies
Asia, Southeastern
Automation
Biological and medical sciences
Cellular Senescence
Cohort Studies
Diseases of red blood cells
Erythrocyte Indices
Genotype
Hematologic and hematopoietic diseases
Hematology - instrumentation
Hemoglobins - metabolism
Humans
Investigative techniques, diagnostic techniques (general aspects)
Mass Screening
Medical sciences
Population screening
Red blood cell indices
Reproducibility of Results
ROC Curve
Thalassemia - blood
Thalassemia - diagnosis
Thalassemia - genetics
Thalassemia - pathology
Thalassemia and hemoglobinopathies
URIT-2900 Hematology Analyzer
title Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A04%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20URIT-2900%20Automated%20Hematology%20Analyzer%20for%20screening%20of%20thalassemia%20and%20hemoglobinopathies%20in%20Southeast%20Asian%20populations&rft.jtitle=Clinical%20biochemistry&rft.au=Karnpean,%20Rossarin&rft.date=2011-07-01&rft.volume=44&rft.issue=10&rft.spage=889&rft.epage=893&rft.pages=889-893&rft.issn=0009-9120&rft.eissn=1873-2933&rft_id=info:doi/10.1016/j.clinbiochem.2011.04.009&rft_dat=%3Cproquest_cross%3E871965676%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=871965676&rft_id=info:pmid/21539820&rft_els_id=S0009912011003146&rfr_iscdi=true